Public Summary: 1 - Anko Face Sunscreen Lotion SPF50+ No Tint
Public Summary: 1 - Anko Face Sunscreen Lotion SPF50+ No Tint
Public Summary: 1 - Anko Face Sunscreen Lotion SPF50+ No Tint
Summary for ARTG Entry: 318247 Anko Face Sunscreen Lotion SPF50+ No Tint
Conditions
The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine, (b)
Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is sub-contracted
to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be kept.
The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records to the
Complementary Medicines Branch, Therapeutic Goods Administration, upon request.
The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted in
relation to the inclusion of the medicine in the Register.
Public Summary
All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office of
Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors of listed
medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified of the report
or reports.
The sponsor shall not supply the listed medicine after the expiry date of the goods.
Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine outside
Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National Manager
Therapeutic Goods Administration, immediately the action or information is known to the sponsor.
Products
Permitted Indications
May assist in preventing some skin cancers (sunscreen)
May reduce the risk of some skin cancers (sunscreen)
SPF 50 PLUS Broad spectrum very high protection sunscreen
Can aid in the prevention of premature skin ageing (sunscreen)
Can aid in the prevention of solar keratosis (sunscreen)
Can aid in the prevention of sunspots (sunscreen)
Indication Requirements
Indication can only be used for sunscreen products with an SPF rating of 30 or higher.
Indication for use in sunscreen products only.
Standard Indications
Specific Indications
Warnings
Components
1 . Formulation 1
Active Ingredients
Aloe vera
aluminium magnesium silicate
Public Summary
cetostearyl alcohol
dimeticone 100
dl-alpha-tocopheryl acetate
edetate sodium
Fragrance (perfume)
isopropyl palmitate
neopentyl glycol diheptanoate
polyglyceryl-3 diisostearate
purified water
silicon dioxide
stearic acid
trolamine
xanthan gum
© Commonwealth of Australia. This work is copyright. You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior
written approval from the Commonwealth. Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.